Why the study?
Data on the role of Lp(a) in non-large-artery ischemic subtypes and hemorrhagic stroke remain limited and inconsistent, and the clinical benefits of Lp(a)-targeted therapies for cerebrovascular disease require further evaluation.
Design
Narrative review
Authors
Loading...
Lp(a) elevation supports risk stratification in large-artery atherosclerotic stroke; leaves open its role in other subtypes and hemorrhage.
Key points are not available for this paper at this time.
Palaiodimou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: